Literature DB >> 31790376

Defining cerebrospinal fluid HIV RNA escape: editorial review AIDS.

Alan Winston1, Andrea Antinori2, Paola Cinque3, Howard S Fox4, Magnus Gisslen5, Timothy J Henrich6, Scott Letendre7, Deborah Persaud8, Richard W Price9, Serena Spudich10.   

Abstract

: Suppression of plasma HIV RNA is most often attainable with effective antiretroviral therapy. Despite this, in some individuals, detection of HIV RNA remains evident in the cerebrospinal fluid (CSF) which is generally termed CSF HIV RNA escape. Defining CSF HIV RNA escape from a virological point of view, a symptomatology point of view and its management has many challenges with several different definitions being utilized. In this editorial, we outline proposed consensus definitions of CSF HIV RNA escape with consideration of virological, symptomatology and management aspects of this condition.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31790376     DOI: 10.1097/QAD.0000000000002252

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  14 in total

Review 1.  Pharmacologic approaches to HIV-associated neurocognitive disorders.

Authors:  Sean N Avedissian; Shetty Ravi Dyavar; Howard S Fox; Courtney V Fletcher
Journal:  Curr Opin Pharmacol       Date:  2020-10-10       Impact factor: 5.547

Review 2.  HIV Compartmentalization in the CNS and Its Impact in Treatment Outcomes and Cure Strategies.

Authors:  Phillip Chan; Serena Spudich
Journal:  Curr HIV/AIDS Rep       Date:  2022-05-10       Impact factor: 5.071

Review 3.  Neuropathogenesis of HIV-1: insights from across the spectrum of acute through long-term treated infection.

Authors:  Lauren Killingsworth; Serena Spudich
Journal:  Semin Immunopathol       Date:  2022-07-26       Impact factor: 11.759

Review 4.  Neuroimmunology of CNS HIV Infection: A Narrative Review.

Authors:  Ana-Claire Meyer; Alfred Kongnyu Njamnshi; Magnus Gisslen; Richard W Price
Journal:  Front Neurol       Date:  2022-06-14       Impact factor: 4.086

5.  Association of High Ratio of CSF/Plasma HIV-1 RNA with Central Nervous System Co-Infection in HIV-1-Positive Treatment-Naive Patients.

Authors:  Qian Liu; Wendan Tao; Honghong Yang; Yushan Wu; Qing Yu; Min Liu
Journal:  Brain Sci       Date:  2022-06-16

6.  Reversal of CSF HIV-1 Escape during Treatment of HIV-Associated Cryptococcal Meningitis in Botswana.

Authors:  Nametso Kelentse; Sikhulile Moyo; Kesaobaka Molebatsi; Olorato Morerinyane; Shatho Bitsang; Ontlametse T Bareng; Kwana Lechiile; Tshepo B Leeme; David S Lawrence; Ishmael Kasvosve; Rosemary Musonda; Mosepele Mosepele; Thomas S Harrison; Joseph N Jarvis; Simani Gaseitsiwe
Journal:  Biomedicines       Date:  2022-06-13

Review 7.  Lessons for Understanding Central Nervous System HIV Reservoirs from the Last Gift Program.

Authors:  Patricia K Riggs; Antoine Chaillon; Guochun Jiang; Scott L Letendre; Yuyang Tang; Jeff Taylor; Andrew Kaytes; Davey M Smith; Karine Dubé; Sara Gianella
Journal:  Curr HIV/AIDS Rep       Date:  2022-10-19       Impact factor: 5.495

8.  Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression.

Authors:  Magnus Gisslen; Sheila M Keating; Serena Spudich; Victor Arechiga; Sophie Stephenson; Henrik Zetterberg; Clara Di Germanio; Kaj Blennow; Dietmar Fuchs; Lars Hagberg; Philip J Norris; Julia Peterson; Barbara L Shacklett; Constantin T Yiannoutsos; Richard W Price
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

9.  Minimal detection of cerebrospinal fluid escape after initiation of antiretroviral therapy in acute HIV-1 infection.

Authors:  Ryan Handoko; Phillip Chan; Linda Jagodzinski; Suteeraporn Pinyakorn; Sasiwimol Ubolyam; Nittaya Phanuphak; Carlo Sacdalan; Eugene Kroon; Netsiri Dumrongpisutikul; Robert Paul; Victor Valcour; Jintanat Ananworanich; Sandhya Vasan; Serena Spudich
Journal:  AIDS       Date:  2021-04-01       Impact factor: 4.632

10.  Cerebrospinal fluid soluble CD30 elevation despite suppressive antiretroviral therapy in individuals living with HIV-1.

Authors:  Michael J Peluso; Cassandra Thanh; Cecilia A Prator; Louise E Hogan; Victor M Arechiga; Sophie Stephenson; Philip J Norris; Clara Di Germanio; Dietmar Fuchs; Henrik Zetterberg; Steven G Deeks; Magnus Gisslén; Richard W Price; Timothy J Henrich
Journal:  J Virus Erad       Date:  2020-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.